People · Operator

Daniel B. Neuwirth

Named in public records as an officer, director or promoter · active 2015–2016 · Healthtech

1
Companies
2
Filings
$20.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Envera Health, Inc.HealthtechSeries A$20.4M$8.5M2015
Operator network

Daniel B. Neuwirth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian Carney · 10 companies · 1 sharedBrian CarneyJ. Robert Mooney · 8 companies · 1 sharedJ. Robert MooneyDaniel Neuwirth · 7 companies · 1 sharedDaniel NeuwirthRobert Mooney · 4 companies · 1 sharedRobert MooneySpence McClelland · 4 companies · 1 sharedSpence McClellandDavid Cerino · 2 companies · 1 sharedDavid CerinoJim Riley · 2 companies · 1 sharedJim RileySusan Olyha · 2 companies · 1 sharedSusan OlyhaCheryl Michael · 1 companies · 1 sharedCheryl MichaelErinne Dyer · 1 companies · 1 sharedErinne DyerJim Robert Riley · 1 companies · 1 sharedJim Robert RileyJohanna Epstein · 1 companies · 1 sharedJohanna EpsteinNancy Van Maren · 1 companies · 1 sharedNancy Van MarenSuran Olyha · 1 companies · 1 sharedSuran OlyhaTammy Mullins · 1 companies · 1 sharedTammy MullinsEnvera Health, Inc. · $20.4M raisedEnvera Health, Inc.Daniel B. NeuwirthDN
Daniel B. Neuwirth Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Daniel B. Neuwirth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Carney110
J. Robert Mooney18
Daniel Neuwirth17
Robert Mooney14
Spence McClelland14
Susan Olyha12
Jim Riley12
David Cerino12
Jim Robert Riley11
Suran Olyha11
Tammy Mullins11
Nancy Van Maren11
Erinne Dyer11
Johanna Epstein11
Cheryl Michael11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.